SENORES PHARMACEUTICALS L (SENORES) — Capital Reinvestment Ratio

Latest as of September 2025: 3.99x

SENORES PHARMACEUTICALS L (SENORES) has a Capital Reinvestment Ratio of 3.99x as of September 2025, meaning it reinvests 4% of its operating cash flow (Rs242.20 Million) in capital expenditures (Rs966.90 Million). See net asset quality index of SENORES PHARMACEUTICALS L to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

3.99x

Capex / Operating Cash Flow

Operating Cash Flow

Rs242.20 Million

INR

Capital Expenditures

Rs966.90 Million

INR

Data as of

Sep 2025

Most recent filing

Annual Capital Reinvestment Ratio for SENORES PHARMACEUTICALS L (None–None)

Year-by-year Capital Reinvestment Ratio for SENORES PHARMACEUTICALS L from None to None. For live market cap and broader valuation context, see how much is SENORES PHARMACEUTICALS L worth.

Year	Reinvestment Ratio	Operating CF (INR)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow